N,N-dimethyl-3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;3-(1-ethylpyrazol-4-yl)-6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinoline;6-[(6-ethyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-3-(1-methylpyrazol-4-yl)quinoline;7-fluoro-3-(1-methylpyrazol-4-yl)-6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinoline;N-methyl-3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-3-(1-propylpyrazol-4-yl)quinoline;1-[4-[6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinolin-3-yl]pyrazol-1-yl]cyclobutane-1-carboxylic acid
C168H150FN59O2 — CID 158878563
Data last refreshed: (MolForge compound catalog, from PubChem)
About N,N-dimethyl-3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;3-(1-ethylpyrazol-4-yl)-6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinoline;6-[(6-ethyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-3-(1-methylpyrazol-4-yl)quinoline;7-fluoro-3-(1-methylpyrazol-4-yl)-6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinoline;N-methyl-3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-3-(1-propylpyrazol-4-yl)quinoline;1-[4-[6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinolin-3-yl]pyrazol-1-yl]cyclobutane-1-carboxylic acid
N,N-dimethyl-3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;3-(1-ethylpyrazol-4-yl)-6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinoline;6-[(6-ethyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-3-(1-methylpyrazol-4-yl)quinoline;7-fluoro-3-(1-methylpyrazol-4-yl)-6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinoline;N-methyl-3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-3-(1-propylpyrazol-4-yl)quinoline;1-[4-[6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinolin-3-yl]pyrazol-1-yl]cyclobutane-1-carboxylic acid (PubChem CID 158878563) has the molecular formula C168H150FN59O2 and a molecular weight of 3046.46 g/mol. Its IUPAC name is N,N-dimethyl-3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;3-(1-ethylpyrazol-4-yl)-6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinoline;6-[(6-ethyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-3-(1-methylpyrazol-4-yl)quinoline;7-fluoro-3-(1-methylpyrazol-4-yl)-6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinoline;N-methyl-3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-3-(1-propylpyrazol-4-yl)quinoline;1-[4-[6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinolin-3-yl]pyrazol-1-yl]cyclobutane-1-carboxylic acid.
Molecular Properties
| Compound Name | N,N-dimethyl-3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;3-(1-ethylpyrazol-4-yl)-6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinoline;6-[(6-ethyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-3-(1-methylpyrazol-4-yl)quinoline;7-fluoro-3-(1-methylpyrazol-4-yl)-6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinoline;N-methyl-3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-3-(1-propylpyrazol-4-yl)quinoline;1-[4-[6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinolin-3-yl]pyrazol-1-yl]cyclobutane-1-carboxylic acid |
|---|---|
| PubChem CID | 158878563 |
| Molecular Formula | C168H150FN59O2 |
| Molecular Weight | 3046.46 g/mol |
| Exact Mass | 3044.34 |
| IUPAC Name | N,N-dimethyl-3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;3-(1-ethylpyrazol-4-yl)-6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinoline;6-[(6-ethyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-3-(1-methylpyrazol-4-yl)quinoline;7-fluoro-3-(1-methylpyrazol-4-yl)-6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinoline;N-methyl-3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;3-[[3-(1-methylpyrazol-4-yl)quinolin-6-yl]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-3-(1-propylpyrazol-4-yl)quinoline;1-[4-[6-[(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinolin-3-yl]pyrazol-1-yl]cyclobutane-1-carboxylic acid |
| SMILES | CCCn1cc(-c2cnc3ccc(Cc4nnc5ccc(C)nn45)cc3c2)cn1.CCc1ccc2nnc(Cc3ccc4ncc(-c5cnn(C)c5)cc4c3)n2n1.CCn1cc(-c2cnc3ccc(Cc4nnc5ccc(C)nn45)cc3c2)cn1.CN(C)c1ccc2nnc(Cc3ccc4ncc(-c5cnn(C)c5)cc4c3)n2n1.CNc1ccc2nnc(Cc3ccc4ncc(-c5cnn(C)c5)cc4c3)n2n1.Cc1ccc2nnc(Cc3cc4cc(-c5cnn(C)c5)cnc4cc3F)n2n1.Cc1ccc2nnc(Cc3ccc4ncc(-c5cnn(C6(C(=O)O)CCC6)c5)cc4c3)n2n1.Cn1cc(-c2cnc3ccc(Cc4nnc5ccc(N)nn45)cc3c2)cn1 |
| InChI | InChI=1S/C24H21N7O2.C22H21N7.C21H20N8.2C21H19N7.C20H16FN7.C20H18N8.C19H16N8/c1-15-3-6-21-27-28-22(31(21)29-15)10-16-4-5-20-17(9-16)11-18(12-25-20)19-13-26-30(14-19)24(23(32)33)7-2-8-24;1-3-8-28-14-19(13-24-28)18-11-17-9-16(5-6-20(17)23-12-18)10-22-26-25-21-7-4-15(2)27-29(21)22;1-27(2)20-7-6-19-24-25-21(29(19)26-20)9-14-4-5-18-15(8-14)10-16(11-22-18)17-12-23-28(3)13-17;1-3-27-13-18(12-23-27)17-10-16-8-15(5-6-19(16)22-11-17)9-21-25-24-20-7-4-14(2)26-28(20)21;1-3-18-5-7-20-24-25-21(28(20)26-18)9-14-4-6-19-15(8-14)10-16(11-22-19)17-12-23-27(2)13-17;1-12-3-4-19-24-25-20(28(19)26-12)7-13-5-14-6-15(16-10-23-27(2)11-16)9-22-18(14)8-17(13)21;1-21-18-5-6-19-24-25-20(28(19)26-18)8-13-3-4-17-14(7-13)9-15(10-22-17)16-11-23-27(2)12-16;1-26-11-15(10-22-26)14-8-13-6-12(2-3-16(13)21-9-14)7-19-24-23-18-5-4-17(20)25-27(18)19/h3-6,9,11-14H,2,7-8,10H2,1H3,(H,32,33);4-7,9,11-14H,3,8,10H2,1-2H3;4-8,10-13H,9H2,1-3H3;2*4-8,10-13H,3,9H2,1-2H3;3-6,8-11H,7H2,1-2H3;3-7,9-12H,8H2,1-2H3,(H,21,26);2-6,8-11H,7H2,1H3,(H2,20,25) |
| InChIKey | JCTCVXXZQOLAIM-UHFFFAOYSA-N |
| XLogP | 24.72 |
| TPSA | 668.91 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 60 |
| Rotatable Bonds | 32 |
| Heavy Atoms | 230 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3046.46 |
| LogP ≤ 5 | 24.72 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 60 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158878563 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.